U.S. stock futures opened mixed Monday morning as market participants processed a pronounced slump in the global memory-chip complex alongside developments in the biotechnology sector.
By 05:45 ET, S&P 500 futures were down 0.25%, Nasdaq 100 futures had slipped 0.9%, and Dow Jones futures were up 0.12%.
Semiconductor and memory-related stocks came under widespread pressure after steep losses at South Korean memory-chip firms spilled over to their U.S.-listed counterparts. At the same time, select biotechnology names attracted buying interest following fresh financing disclosures.
Notable premarket movers
- Agenus rallied roughly 13% after the biotechnology company disclosed an $85 million private placement led by Commodore Capital, with additional participation from a group of life sciences investors. The firm said the financing could expand to as much as $340 million if all purchase warrants are exercised. Company management indicated the proceeds are intended to fund its Phase 3 ROBBIN trial and to extend the company’s cash runway through the end of 2031.
- Micron Technology fell about 5.1% following a more than 15% plunge in shares of South Korean memory-chip maker SK Hynix in Asian trading, a move that precipitated a broader selloff across the memory sector.
- Western Digital dropped roughly 5.4% as weakness in memory and storage names widened. The company’s decline came after sharp losses at SK Hynix and Samsung Electronics, developments that dampened sentiment for firms with exposure to memory-chip demand and pricing.
Investor caution was reinforced by a South Korean brokerage’s forecast that second-quarter earnings for SK Hynix would come in below market expectations. That projection cited slower-than-anticipated shipments of next-generation high-bandwidth memory chips as a contributing factor.
The market response illustrates how quickly regional earnings and shipment outlooks can affect global sector sentiment, transmitting moves from Asian equity markets into premarket activity in the United States.
This piece highlights premarket price moves and company announcements; it reports the data and statements provided and does not attempt to assess longer-term implications beyond the information disclosed.